Long-term use of lenalidomide and low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma: MM-024 Extended Access Program
Crossref DOI link: https://doi.org/10.1186/s12885-016-2069-8
Published Online: 2016-01-28
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Du, Xin
Jin, Jie
Cai, Zhen
Chen, Fangping
Zhou, Dao-bin
Yu, Li
Ke, Xiaoyan
Li, Xiao
Wu, Depei
Meng, Fanyi
DeMarco, Dena
Zhang, Jingshan
Mei, Jay
Hou, Jian
Funding for this research was provided by:
Celgene (US)
Tigermed
